Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032]

Heliyon（2023）

引用 0|浏览6

暂无评分

摘要

[This corrects the article DOI: 10.1016/j.heliyon.2023.e15032.].

查看译文

关键词

potential generalizable therapeutic antibodies,antibody 80r,nanomolar-binding,sars-cov

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要